Tonix Pharmaceuticals (TNXP) Revenue & Revenue Breakdown
Tonix Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$7.77M
Latest Revenue (Q)
$2.21M
Tonix Pharmaceuticals Revenue by Period
Tonix Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $7.77M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | - |
Tonix Pharmaceuticals generated $7.77M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Tonix Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $2.21M | -11.04% |
| 2024-03-31 | $2.48M | -34.32% |
| 2023-12-31 | $3.78M | -5.26% |
| 2023-09-30 | $3.99M | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $33.90M | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $9.74M | 7.89% |
| 2022-06-30 | $9.03M | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $2.91M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $-500.00 | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | - |
Tonix Pharmaceuticals generated $2.21M in revenue during Q2 2024, up -11.04% compared to the previous quarter, and up 6.51% compared to the same period a year ago.
Tonix Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ONTX | Traws Pharma | $226.00B | $56.00K |
| NVAX | Novavax | $983.71M | $93.86M |
| INO | Inovio Pharmaceuticals | $832.01M | - |
| JAGX | Jaguar Health | $9.76M | $2.72M |
| VBIV | VBI Vaccines | $8.68M | $1.21M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.21M |
| VXRT | Vaxart | $7.38M | $6.40M |
| PALI | Palisade Bio | $250.00K | - |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CWBR | CohBar | - | - |
| DRUG | Bright Minds Biosciences | - | - |
| ENVB | Enveric Biosciences | - | - |
| DFFN | CervoMed | - | - |
| ACST | Acasti Pharma | - | - |
TNXP Revenue FAQ
What is Tonix Pharmaceuticals’s yearly revenue?
Tonix Pharmaceuticals's yearly revenue for 2023 was $7.77M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TNXP's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Tonix Pharmaceuticals’s quarterly revenue?
Tonix Pharmaceuticals's quarterly revenue for Q2 2024 was $2.21M, a -11.04% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.48M, a -34.32% decrease from the previous quarter (Q4 2023), and a -92.68% decrease year-over-year (Q1 2023). TNXP's quarterly revenue for Q4 2023 was $3.78M, a -5.26% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Tonix Pharmaceuticals’s revenue growth rate?
Tonix Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.